A244460 Stock Overview
A biotech company, focuses on developing therapeutic products in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
OLIPASS Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩5,800.00 |
| 52 Week High | ₩9,250.00 |
| 52 Week Low | ₩4,210.00 |
| Beta | 0.50 |
| 1 Month Change | 21.59% |
| 3 Month Change | -16.19% |
| 1 Year Change | -25.55% |
| 3 Year Change | -93.67% |
| 5 Year Change | -96.27% |
| Change since IPO | -96.49% |
Recent News & Updates
Shareholder Returns
| A244460 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | -3.5% | 0.1% | -1.6% |
| 1Y | -25.5% | 16.9% | -9.1% |
Return vs Industry: A244460 underperformed the KR Biotechs industry which returned 16.9% over the past year.
Return vs Market: A244460 underperformed the KR Market which returned -9.1% over the past year.
Price Volatility
| A244460 volatility | |
|---|---|
| A244460 Average Weekly Movement | 12.0% |
| Biotechs Industry Average Movement | 8.7% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.6% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A244460's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A244460's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 78 | Shin Chung | www.olipass.com |
OLIPASS Corporation, a biotech company, focuses on developing therapeutic products in South Korea. The company develops its products using its novel PNA based technologies. Its products pipeline includes SCN9A, a product candidate that is in Phase II clinical trials for the treatment of pain.
OLIPASS Corporation Fundamentals Summary
| A244460 fundamental statistics | |
|---|---|
| Market cap | ₩26.45b |
| Earnings (TTM) | -₩16.72b |
| Revenue (TTM) | ₩5.25b |
4.8x
P/S Ratio-1.5x
P/E RatioIs A244460 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A244460 income statement (TTM) | |
|---|---|
| Revenue | ₩5.25b |
| Cost of Revenue | ₩655.19m |
| Gross Profit | ₩4.60b |
| Other Expenses | ₩21.31b |
| Earnings | -₩16.72b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.81k |
| Gross Margin | 87.52% |
| Net Profit Margin | -318.36% |
| Debt/Equity Ratio | 193.0% |
How did A244460 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 16:23 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
OLIPASS Corporation is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Taehee Kim | Mirae Asset Securities Co., Ltd. |
| Keunhee Seo | Samsung Securities Co. Ltd. |